Andone Pharma

Class [005]
Anti-diabetic pharmaceuticals; anti-epileptic pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; anti-inflammatory pharmaceutical preparations; antidiabetic pharmaceuticals; antiepileptic pharmaceutical preparations; antifungal pharmaceutical preparations; antiviral pharmaceutical preparations; dermatological pharmaceutical preparations for the treatment of bacterial skin infections; dermatological pharmaceutical preparations for the treatment of dermatitis, skin pigmentation diseases and psoriasis; dermatological pharmaceuticals for the treatment of plaque psoriasis; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the relief of pain; human pharmaceuticals for treatment of cancer; human pharmaceuticals for treatment of prostate cancer; injectable pharmaceuticals for treatment of anaphylactic reactions; injectable preparations made of solutions of hyaluronic acid for medical and pharmaceutical purposes; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; intravenous fluids used for the delivery of pharmaceutical preparations; neurological and psychological pharmaceutical preparations for the treatment of chemical dependency; neurological and psychological pharmaceutical preparations for the treatment of drug addictions; neurological and psychological pharmaceutical preparations for the treatment of eating disorders and addictions; neurological pharmaceutical preparations for the prevention and treatment of Alzheimer's, Huntington's disease, and cerebral palsy; opioid antagonist pharmaceutical preparations; pharmaceutical agents for treating physically caused lesions; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the musculo-skeletal system; pharmaceutical and biological preparations for medical use, namely, for use in oncology, hematology and in tissue and organ transplantation; pharmaceutical anti-allergic medications; pharmaceutical anti-allergic preparations and substances; pharmaceutical anti-infectives; pharmaceutical anti-inflammatories; pharmaceutical anti-viral agents; pharmaceutical antiallergic preparations and substances; pharmaceutical antibodies for the treatment of hereditary angioedema (HAE); pharmaceutical antibodies for the treatment of respiratory diseases and respiratory syndromes; pharmaceutical antibody preparations for auto-immune diseases; pharmaceutical antibody preparations for respiratory disease; pharmaceutical antibody preparations for the prevention and treatment of auto-immune diseases; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical antitussive-cold preparations; pharmaceutical anxiolytic medications; pharmaceutical astringents; pharmaceutical cold preparations; pharmaceutical creams that facilitate the topical administration of pharmaceuticals for the treatment of dermatological conditions being dermatitis, eczema and psoriasis; pharmaceutical preparations and substances for the treatment of diabetes; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of dermatitis, eczema and psoriasis; veterinary pharmaceutical preparations for animals and poultry to give newborn animals and birds a healthy start; veterinary pharmaceutical preparations for the prevention and treatment of iron deficiency and anaemia in animals; veterinary pharmaceutical preparations for the prevention and treatment of iron deficiency and anemia in animals; veterinary pharmaceutical preparations for the treatment of bacterial infections in dogs; veterinary pharmaceutical preparations for the treatment of swine bacterial infectious diseases; veterinary pharmaceutical preparations for the treatment of vitamin deficiencies;; veterinary pharmaceuticals for parturition induction in swine